Trial intelligence / Profile preview

FST-LIBERATE

NCT06229990Phase 4Recruiting

Sponsor
Chiang Mai University
Start
Jan 2024
Primary completion
Dec 2028
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of furosemide in acute kidney injury (AKI), sponsored by Chiang Mai University. Started Jan 2024; status: recruiting.

02

Drugs

furosemide
03

Conditions

acute kidney injury (AKI)

Beyond the preview

Go deeper on NCT06229990.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06229990.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call